Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN vs DALBAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABIGATRAN vs DALBAVANCIN: Safety Overview

Metric DABIGATRAN DALBAVANCIN
Total FAERS Reports 2,080 1,107
Deaths Reported 251 54
Death Rate 12.1% 4.9%
Hospitalizations 1,309 288
Average Patient Age 71.7 yrs 61.0 yrs
% Female Patients 36.3% 46.7%
FDA Approval Date N/A May 23, 2014
Manufacturer N/A Fresenius Kabi USA, LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription